Burger CW - Search Results

1

Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.

Meeuwissen PA, Seynaeve C, Brekelmans CT, Meijers-Heijboer HJ, Klijn JG, Burger CW. Meeuwissen PA, et al. Among authors: burger cw. Gynecol Oncol. 2005 May;97(2):476-82. doi: 10.1016/j.ygyno.2005.01.024. Gynecol Oncol. 2005. PMID: 15863147

2

The incidence of parametrial tumor involvement in select patients with early cervix cancer is too low to justify parametrectomy.

Stegeman M, Louwen M, van der Velden J, ten Kate FJ, den Bakker MA, Burger CW, Ansink AC. Stegeman M, et al. Among authors: burger cw. Gynecol Oncol. 2007 May;105(2):475-80. doi: 10.1016/j.ygyno.2007.01.016. Epub 2007 Feb 9. Gynecol Oncol. 2007. PMID: 17292460

3

Primitive neuroectodermal tumor of the cervix uteri: a case report -- changing concepts in therapy.

Snijders-Keilholz A, Ewing P, Seynaeve C, Burger CW. Snijders-Keilholz A, et al. Among authors: burger cw. Gynecol Oncol. 2005 Sep;98(3):516-9. doi: 10.1016/j.ygyno.2005.05.020. Gynecol Oncol. 2005. PMID: 15979131 Review.

4

Occult cancer in the fallopian tube in patients with a BRCA-1 germline mutation.

Ansink AC, Burger CW, Seynaeve C. Ansink AC, et al. Among authors: burger cw. Gynecol Oncol. 2001 Nov;83(2):445. doi: 10.1006/gyno.2001.6290. Gynecol Oncol. 2001. PMID: 11606115 No abstract available.

5

Gene expression profiling in human endometrial cancer tissue samples: utility and diagnostic value.

Smid-Koopman E, Blok LJ, Helmerhorst TJ, Chadha-Ajwani S, Burger CW, Brinkmann AO, Huikeshoven FJ. Smid-Koopman E, et al. Among authors: burger cw. Gynecol Oncol. 2004 May;93(2):292-300. doi: 10.1016/j.ygyno.2004.01.022. Gynecol Oncol. 2004. PMID: 15099936

6

Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients.

Vencken PMLH, Kriege M, Hoogwerf D, Beugelink S, van der Burg MEL, Hooning MJ, Berns EM, Jager A, Collée M, Burger CW, Seynaeve C. Vencken PMLH, et al. Among authors: burger cw. Ann Oncol. 2011 Jun;22(6):1346-1352. doi: 10.1093/annonc/mdq628. Epub 2011 Jan 12. Ann Oncol. 2011. PMID: 21228333

7

Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands.

Vencken PM, Reitsma W, Kriege M, Mourits MJ, de Bock GH, de Hullu JA, van Altena AM, Gaarenstroom KN, Vasen HF, Adank MA, Schmidt MK, van Beurden M, Zweemer RP, Rijcken F, Slangen BF, Burger CW, Seynaeve C. Vencken PM, et al. Among authors: burger cw. Ann Oncol. 2013 Aug;24(8):2036-42. doi: 10.1093/annonc/mdt068. Epub 2013 Mar 29. Ann Oncol. 2013. PMID: 23543211

8

Stage III and IV endometrial cancer: a 20-year review of patients.

van Wijk FH, Huikeshoven FJ, Abdulkadir L, Ewing PC, Burger CW. van Wijk FH, et al. Among authors: burger cw. Int J Gynecol Cancer. 2006 Jul-Aug;16(4):1648-55. doi: 10.1111/j.1525-1438.2006.00639.x. Int J Gynecol Cancer. 2006. PMID: 16884379

9

What is the role of dose-dense therapy?

van der Burg ME, van der Gaast A, Vergote I, Burger CW, van Doorn HC, de Wit R, Stoter G, Verweij J. van der Burg ME, et al. Among authors: burger cw. Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:233-40. doi: 10.1111/j.1525-1438.2005.00432.x. Int J Gynecol Cancer. 2005. PMID: 16343238 Review.

10

Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.

Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Ouweland AW, van Geel B, Klijn JG. Meijers-Heijboer H, et al. J Clin Oncol. 2003 May 1;21(9):1675-81. doi: 10.1200/JCO.2003.09.052. J Clin Oncol. 2003. PMID: 12721241

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results